Primary radiation therapy for advanced‐stage laryngeal cancer: A laryngo‐esophageal dysfunction disease‐free survival
Authors:
Open Access
- 23 November 2022
- journal article
- research article
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 7 (6) , 1866-1874
Abstract
ObjectivesTo evaluate the outcomes of advanced-stage laryngeal squamous cell carcinoma (SCC) patients treated with functional-preservation strategy with a specific focus on laryngo-esophageal dysfunction disease-free survival (LEDDFS).Methods and materialsA retrospective review was conducted of stage III-IVB laryngeal SCC patients who were treated with curative-intent radiotherapy (RT) (2007-2018). Patients were preferentially managed with upfront chemoradiation (CCRT); except for those with cN2-3, cT4, or large volume cT3 (induction chemotherapy followed by RT or CCRT is an option), and those who were unfit or declined chemotherapy (received altered RT). The primary endpoint was 3-year LEDDFS, and secondary endpoints were 3-year local failure (LF), regional failure (RF), distant metastasis (DM), overall survival (OS), disease-free survival (DFS), and acute and late toxicities. Cox proportional hazard tests were used for multivariable analysis (MVA).ResultsA total of 213 cases were included. With a median follow-up of 37 months, the 3-year LEDDFS was 50%, while the 3-year OS, DFS, LF, RF, and DM were 81%, 74%, 9%, 5%, and 7%, respectively. On MVA, cT4-category was the only predictor of inferior LEDDFS (HR: 0.47, [95% CI: 0.29-0.74], p < .01). The most common grade & GE; 3 acute and late radiation therapy oncology group (RTOG) toxicity were esophageal toxicity: 16.7% and 29.6%, respectively.ConclusionsPrimary RT resulted in favorable oncologic and functional outcomes in only half of the advanced-stage laryngeal cancer patients. Future clinical trials are required to investigate further treatment options aiming to improve the oncologic and maintain functional outcomes with utilization of LEDDFS as the primary endpoint.Level of evidence4.Keywords
This publication has 38 references indexed in Scilit:
- The Effect of Treating Institution on Outcomes in Head and Neck CancerOtolaryngology–Head and Neck Surgery, 2012
- Nutritional surveillance and weight loss in head and neck cancer patientsSupportive Care in Cancer, 2011
- Larynx preservation with primary non‐surgical treatment for loco‐regionally advanced larynx cancerJournal of Medical Imaging and Radiation Oncology, 2011
- Examination of laryngoesophageal dysfunction‐free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynxCancer, 2011
- The Effect of treatment on survival in patients with advanced laryngeal carcinomaThe Laryngoscope, 2009
- Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and RadiotherapyJNCI: Journal of the National Cancer Institute, 2009
- Comorbidity Is a Prognostic Factor in Elderly Patients with Head and Neck CancerAnnals of Surgical Oncology, 2007
- Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal CancerNew England Journal of Medicine, 2003
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI: Journal of the National Cancer Institute, 1996
- Speech and SurvivalNew England Journal of Medicine, 1981